Perillyl alcohol — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-30 in 2mo
ESTIMATED |
READOUT
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutat
Phase 1/2 · Glioblastoma Multiforme |
NTHI NEONC TECHNOLOGIES HOLDINGS, | Perillyl alcohol |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|